nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Vinorelbine—ovarian cancer	0.0868	0.0868	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Epirubicin—ovarian cancer	0.0334	0.0334	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Doxorubicin—ovarian cancer	0.0309	0.0309	CcSEcCtD
Clavulanate—Induration—Paclitaxel—ovarian cancer	0.0262	0.0262	CcSEcCtD
Clavulanate—Leukopenia—Altretamine—ovarian cancer	0.0252	0.0252	CcSEcCtD
Clavulanate—Convulsion—Altretamine—ovarian cancer	0.0244	0.0244	CcSEcCtD
Clavulanate—Pseudomembranous colitis—Paclitaxel—ovarian cancer	0.0235	0.0235	CcSEcCtD
Clavulanate—Thrombocytopenia—Altretamine—ovarian cancer	0.0225	0.0225	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.0149	0.0149	CcSEcCtD
Clavulanate—Thrombophlebitis—Vinorelbine—ovarian cancer	0.0146	0.0146	CcSEcCtD
Clavulanate—Vomiting—Altretamine—ovarian cancer	0.0146	0.0146	CcSEcCtD
Clavulanate—Nausea—Altretamine—ovarian cancer	0.0136	0.0136	CcSEcCtD
Clavulanate—Pain—Carboplatin—ovarian cancer	0.0136	0.0136	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.0127	0.0127	CcSEcCtD
Clavulanate—Erythema multiforme—Chlorambucil—ovarian cancer	0.0109	0.0109	CcSEcCtD
Clavulanate—Haemoglobin—Topotecan—ovarian cancer	0.0103	0.0103	CcSEcCtD
Clavulanate—Haemorrhage—Topotecan—ovarian cancer	0.0102	0.0102	CcSEcCtD
Clavulanate—Haemoglobin—Melphalan—ovarian cancer	0.0101	0.0101	CcSEcCtD
Clavulanate—Haemorrhage—Melphalan—ovarian cancer	0.01	0.01	CcSEcCtD
Clavulanate—Hepatitis—Melphalan—ovarian cancer	0.01	0.01	CcSEcCtD
Clavulanate—Thrombophlebitis—Paclitaxel—ovarian cancer	0.00982	0.00982	CcSEcCtD
Clavulanate—Swelling—Paclitaxel—ovarian cancer	0.00964	0.00964	CcSEcCtD
Clavulanate—Leukopenia—Chlorambucil—ovarian cancer	0.00895	0.00895	CcSEcCtD
Clavulanate—Convulsion—Chlorambucil—ovarian cancer	0.00866	0.00866	CcSEcCtD
Clavulanate—Thrombophlebitis—Docetaxel—ovarian cancer	0.00832	0.00832	CcSEcCtD
Clavulanate—Swelling—Docetaxel—ovarian cancer	0.00817	0.00817	CcSEcCtD
Clavulanate—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00799	0.00799	CcSEcCtD
Clavulanate—Leukopenia—Topotecan—ovarian cancer	0.00796	0.00796	CcSEcCtD
Clavulanate—Leukopenia—Melphalan—ovarian cancer	0.0078	0.0078	CcSEcCtD
Clavulanate—Hypokalaemia—Paclitaxel—ovarian cancer	0.00774	0.00774	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00766	0.00766	CcSEcCtD
Clavulanate—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00762	0.00762	CcSEcCtD
Clavulanate—Convulsion—Melphalan—ovarian cancer	0.00755	0.00755	CcSEcCtD
Clavulanate—Anaphylactic shock—Topotecan—ovarian cancer	0.00726	0.00726	CcSEcCtD
Clavulanate—Anaphylactic shock—Melphalan—ovarian cancer	0.00711	0.00711	CcSEcCtD
Clavulanate—Thrombocytopenia—Topotecan—ovarian cancer	0.00711	0.00711	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00705	0.00705	CcSEcCtD
Clavulanate—Pain—Chlorambucil—ovarian cancer	0.00698	0.00698	CcSEcCtD
Clavulanate—Thrombocytopenia—Melphalan—ovarian cancer	0.00696	0.00696	CcSEcCtD
Clavulanate—Leukopenia—Vinorelbine—ovarian cancer	0.00681	0.00681	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.0065	0.0065	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00649	0.00649	CcSEcCtD
Clavulanate—Urticaria—Chlorambucil—ovarian cancer	0.00648	0.00648	CcSEcCtD
Clavulanate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00621	0.00621	CcSEcCtD
Clavulanate—Pain—Topotecan—ovarian cancer	0.00621	0.00621	CcSEcCtD
Clavulanate—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00608	0.00608	CcSEcCtD
Clavulanate—Pain—Melphalan—ovarian cancer	0.00608	0.00608	CcSEcCtD
Clavulanate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00601	0.00601	CcSEcCtD
Clavulanate—Haemoglobin—Paclitaxel—ovarian cancer	0.00591	0.00591	CcSEcCtD
Clavulanate—Haemorrhage—Paclitaxel—ovarian cancer	0.00588	0.00588	CcSEcCtD
Clavulanate—Pruritus—Chlorambucil—ovarian cancer	0.00577	0.00577	CcSEcCtD
Clavulanate—Urticaria—Topotecan—ovarian cancer	0.00577	0.00577	CcSEcCtD
Clavulanate—Urticaria—Melphalan—ovarian cancer	0.00565	0.00565	CcSEcCtD
Clavulanate—Thrombophlebitis—Epirubicin—ovarian cancer	0.00561	0.00561	CcSEcCtD
Clavulanate—Diarrhoea—Chlorambucil—ovarian cancer	0.00558	0.00558	CcSEcCtD
Clavulanate—Erythema multiforme—Paclitaxel—ovarian cancer	0.00556	0.00556	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00551	0.00551	CcSEcCtD
Clavulanate—Hypersensitivity—Topotecan—ovarian cancer	0.00535	0.00535	CcSEcCtD
Clavulanate—Pain—Vinorelbine—ovarian cancer	0.00531	0.00531	CcSEcCtD
Clavulanate—Hypersensitivity—Melphalan—ovarian cancer	0.00524	0.00524	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—ovarian cancer	0.0052	0.0052	CcSEcCtD
Clavulanate—Vomiting—Chlorambucil—ovarian cancer	0.00519	0.00519	CcSEcCtD
Clavulanate—Pruritus—Topotecan—ovarian cancer	0.00514	0.00514	CcSEcCtD
Clavulanate—Pruritus—Melphalan—ovarian cancer	0.00503	0.00503	CcSEcCtD
Clavulanate—Haemoglobin—Docetaxel—ovarian cancer	0.00501	0.00501	CcSEcCtD
Clavulanate—Haemorrhage—Docetaxel—ovarian cancer	0.00499	0.00499	CcSEcCtD
Clavulanate—Hepatitis—Docetaxel—ovarian cancer	0.00499	0.00499	CcSEcCtD
Clavulanate—Diarrhoea—Topotecan—ovarian cancer	0.00497	0.00497	CcSEcCtD
Clavulanate—Urticaria—Vinorelbine—ovarian cancer	0.00494	0.00494	CcSEcCtD
Clavulanate—Diarrhoea—Melphalan—ovarian cancer	0.00487	0.00487	CcSEcCtD
Clavulanate—Nausea—Chlorambucil—ovarian cancer	0.00485	0.00485	CcSEcCtD
Clavulanate—Erythema multiforme—Docetaxel—ovarian cancer	0.00471	0.00471	CcSEcCtD
Clavulanate—Vomiting—Topotecan—ovarian cancer	0.00462	0.00462	CcSEcCtD
Clavulanate—Leukopenia—Paclitaxel—ovarian cancer	0.00458	0.00458	CcSEcCtD
Clavulanate—Rash—Topotecan—ovarian cancer	0.00458	0.00458	CcSEcCtD
Clavulanate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00458	0.00458	CcSEcCtD
Clavulanate—Dermatitis—Topotecan—ovarian cancer	0.00457	0.00457	CcSEcCtD
Clavulanate—Vomiting—Melphalan—ovarian cancer	0.00452	0.00452	CcSEcCtD
Clavulanate—Rash—Melphalan—ovarian cancer	0.00448	0.00448	CcSEcCtD
Clavulanate—Dermatitis—Melphalan—ovarian cancer	0.00448	0.00448	CcSEcCtD
Clavulanate—Convulsion—Paclitaxel—ovarian cancer	0.00444	0.00444	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—ovarian cancer	0.00442	0.00442	CcSEcCtD
Clavulanate—Pruritus—Vinorelbine—ovarian cancer	0.0044	0.0044	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00438	0.00438	CcSEcCtD
Clavulanate—Nausea—Topotecan—ovarian cancer	0.00431	0.00431	CcSEcCtD
Clavulanate—Diarrhoea—Vinorelbine—ovarian cancer	0.00425	0.00425	CcSEcCtD
Clavulanate—Nausea—Melphalan—ovarian cancer	0.00422	0.00422	CcSEcCtD
Clavulanate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00418	0.00418	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—ovarian cancer	0.00416	0.00416	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—ovarian cancer	0.00409	0.00409	CcSEcCtD
Clavulanate—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00409	0.00409	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00405	0.00405	CcSEcCtD
Clavulanate—Vomiting—Vinorelbine—ovarian cancer	0.00395	0.00395	CcSEcCtD
Clavulanate—Rash—Vinorelbine—ovarian cancer	0.00392	0.00392	CcSEcCtD
Clavulanate—Dermatitis—Vinorelbine—ovarian cancer	0.00391	0.00391	CcSEcCtD
Clavulanate—Leukopenia—Docetaxel—ovarian cancer	0.00388	0.00388	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—ovarian cancer	0.00385	0.00385	CcSEcCtD
Clavulanate—Convulsion—Docetaxel—ovarian cancer	0.00376	0.00376	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00371	0.00371	CcSEcCtD
Clavulanate—Nausea—Vinorelbine—ovarian cancer	0.00369	0.00369	CcSEcCtD
Clavulanate—Pain—Paclitaxel—ovarian cancer	0.00357	0.00357	CcSEcCtD
Clavulanate—Anaphylactic shock—Docetaxel—ovarian cancer	0.00354	0.00354	CcSEcCtD
Clavulanate—Thrombocytopenia—Docetaxel—ovarian cancer	0.00347	0.00347	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00344	0.00344	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—ovarian cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—ovarian cancer	0.00336	0.00336	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—ovarian cancer	0.00336	0.00336	CcSEcCtD
Clavulanate—Urticaria—Paclitaxel—ovarian cancer	0.00332	0.00332	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—ovarian cancer	0.00318	0.00318	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—ovarian cancer	0.00313	0.00313	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—ovarian cancer	0.00311	0.00311	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—ovarian cancer	0.00311	0.00311	CcSEcCtD
Clavulanate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00308	0.00308	CcSEcCtD
Clavulanate—Pain—Docetaxel—ovarian cancer	0.00303	0.00303	CcSEcCtD
Clavulanate—Pruritus—Paclitaxel—ovarian cancer	0.00296	0.00296	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—ovarian cancer	0.00294	0.00294	CcSEcCtD
Clavulanate—Diarrhoea—Paclitaxel—ovarian cancer	0.00286	0.00286	CcSEcCtD
Clavulanate—Vomiting—Paclitaxel—ovarian cancer	0.00266	0.00266	CcSEcCtD
Clavulanate—Rash—Paclitaxel—ovarian cancer	0.00263	0.00263	CcSEcCtD
Clavulanate—Dermatitis—Paclitaxel—ovarian cancer	0.00263	0.00263	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—ovarian cancer	0.00262	0.00262	CcSEcCtD
Clavulanate—Hypersensitivity—Docetaxel—ovarian cancer	0.00261	0.00261	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—ovarian cancer	0.00254	0.00254	CcSEcCtD
Clavulanate—Pruritus—Docetaxel—ovarian cancer	0.00251	0.00251	CcSEcCtD
Clavulanate—Nausea—Paclitaxel—ovarian cancer	0.00248	0.00248	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—ovarian cancer	0.00242	0.00242	CcSEcCtD
Clavulanate—Diarrhoea—Docetaxel—ovarian cancer	0.00242	0.00242	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—ovarian cancer	0.00239	0.00239	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—ovarian cancer	0.00235	0.00235	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—ovarian cancer	0.00234	0.00234	CcSEcCtD
Clavulanate—Vomiting—Docetaxel—ovarian cancer	0.00225	0.00225	CcSEcCtD
Clavulanate—Rash—Docetaxel—ovarian cancer	0.00223	0.00223	CcSEcCtD
Clavulanate—Dermatitis—Docetaxel—ovarian cancer	0.00223	0.00223	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00221	0.00221	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00216	0.00216	CcSEcCtD
Clavulanate—Nausea—Docetaxel—ovarian cancer	0.0021	0.0021	CcSEcCtD
Clavulanate—Pain—Epirubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Clavulanate—Pain—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—ovarian cancer	0.00169	0.00169	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—ovarian cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—ovarian cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Rash—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Clavulanate—Nausea—Epirubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Rash—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
